Role of microneedling in treatment of alopecia areata

Abstract

Background: Alopecia areata (AA) is a hair follicles-related autoimmune illness that produces non- cicatricial alopecia in both the scalp and non-scalp regions. Corticosteroids are beneficial both topically and intralesionally, however injections can be unpleasant in large lesions. Objectives: The goal of this research is to assess the efficiency of microneedling in alopecia areata. Methods: The research involved 20 participants with alopecia areata. Their ages varied from 11 to 45 years. Results: Improvement was observed clinically in the majority of patients, with a rise in hair density and growth in afflicted regions. This began around one month and ended about three months following the final therapy session.